Cell cycle progression score to modify treatment decisions in prostate cancer: Results of an ongoing registry trial.
E. David Crawford
Consultant or Advisory Role - Myriad Genetics
Honoraria - Myriad Genetics
Ashok J. Kar
No relevant relationships to disclose
Mark C. Scholz
Research Funding - Myriad Genetics
Jeffrey E. Fegan
No relevant relationships to disclose
Rajesh R. Kaldate
Employment or Leadership Position - Myriad Genetics
Stock Ownership - Myriad Genetics
Michael K. Brawer
Employment or Leadership Position - Myriad Genetics
Stock Ownership - Myriad Genetics